Recent discoveries that reveal an intricate interplay between p53 and PIPns within the nucleus of cancer cells have significantly advanced our understanding of these pathways (Chen et al., 2020, 2022; Choi et al., 2019; Ren et al., 2024). Here, TP53 is linked to cancer.